Etoposide is a medication used in the management and treatment of various cancers such as testicular, prostate, bladder, stomach, and lung cancer. It is in the topoisomerase II inhibitor class of medications. This activity outlines the indications, action, and contraindications for etoposide as a valuable agent in managing various cancers listed above, Hodgkin and non-Hodgkin lymphoma and brain tumors. (and other disorders when applicable). This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team in the treatment of patients with various cancers, lymphomas, leukemias, and related conditions.

**Objectives:**
- Identify the common indications for the use of etoposide.
- Describe the typical adverse effects of etoposide.
- Review the risk factors for developing toxicity with etoposide.

- Summarize the importance of improving care coordination amongst the interprofessional team to enhance care coordination for patients receiving etoposide chemotherapy.